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Abstract
Background: Literature on the spectrum of opportunistic disease in human immunodeficiency
virus (HIV)-infected patients from developing countries is sparse. The objective of this study was
to document the spectrum and determine the frequency of various opportunistic infections (OIs)
and non-infectious opportunistic diseases, in hospitalised HIV-infected patients from north India.
Methods: One hundred and thirty five consecutive, HIV-infected patients (age 34 ± 10 years,
females 17%) admitted to a tertiary care hospital in north India, for the evaluation and management
of an OI or HIV-related disorder between January 2000 and July 2003, were studied.
Results: Fever (71%) and weight loss (65%) were the commonest presenting symptoms.
Heterosexual transmission was the commonest mode of HIV-acquisition. Tuberculosis (TB) was
the commonest OI (71%) followed by candidiasis (39.3%), Pneumocystis jiroveci pneumonia (PCP)
(7.4%), cryptococcal meningitis and cerebral toxoplasmosis (3.7% each). Most of the cases of TB
were disseminated (64%). Apart from other well-recognised OIs, two patients had visceral
leishmaniasis. Two cases of HIV-associated lymphoma were encountered. CD4+ cell counts were
done in 109 patients. Majority of the patients (82.6%) had CD4+ counts <200 cells/µL. Fifty patients
(46%) had CD4+ counts <50 cells/µL. Only 50 patients (37%) received antiretroviral therapy.
Twenty one patients (16%) died during hospital stay. All but one deaths were due to TB (16
patients; 76%) and PCP (4 patients; 19%).
Conclusions: A wide spectrum of disease, including both OIs and non-infectious opportunistic
diseases, is seen in hospitalised HIV-infected patients from north India. Tuberculosis remains the
most common OI and is the commonest cause of death in these patients.
Background
The first case of human immunodeficiency virus/acquired
immunodeficiency syndrome (HIV/AIDS) in India was
detected in 1986 in the state of Tamilnadu [1] and since
then the spread of HIV/AIDS across the nation has been
relentless. Cases have been reported from all states and
union territories of India. Though the overall prevalence
of HIV infection is low (<1%), the total number of cases
is high. As per estimates, by the end of 2002, about 4.58
million adults were infected with HIV [2]. Even more
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groups such as injectable drug users (IDU) and patients
with other sexually transmitted diseases, to low-risk
groups like married, monogamous women [3].
Though the majority of HIV-infected population lives in
developing nations, there is a paucity of data on natural
history, pattern of disease and survival of hospitalised
patients with HIV/AIDS from these regions, especially
India. It is well established that manifestations of AIDS
are influenced by factors such as endemic infections and
malnutrition that are widely prevalent in these regions
[4]. Conventional disease staging criteria, which were
developed in western populations may not hold good in
these settings [4,5]. Added to this, resource constraints
prohibit evaluation and decision-making based on cost
and labour-intensive methods such as CD4+ cell counts
and viral RNA load estimation. Timely initiation of
prophylaxis for opportunistic infections (OIs) and their
prompt recognition and treatment are the only economi-
cally viable options [6]. In this scenario, knowledge
regarding the pattern of OIs, will be useful. This study was
conducted to elucidate the frequency of various OIs and
non-infectious opportunistic conditions in hospitalised
HIV-infected patients, from north India.
Methods
We describe a series of 135 consecutive patients with HIV/
AIDS, aged 13 years and above, admitted to the All India
Institute of Medical Sciences (A.I.I.M.S.) hospital, New
Delhi during the period of January 2000 through July
2003. A.I.I.M.S. is a large tertiary level teaching hospital
and referral centre located in north India, attending to
HIV-infected patients apart from others. The catchment
area of this hospital includes the New Delhi national cap-
ital territory and neighbouring states mainly, Uttar
Pradesh, Bihar, Uttharanchal, Haryana, Punjab and
Himachal Pradesh. All patients were under the care of a
single unit, of the three units existing in the Department
of Medicine. Decision to admit was taken by the treating
physician and all patients were hospitalised for the evalu-
ation and treatment of a suspected OI or HIV-related dis-
order. We have earlier reported the determinants of in-
hospital mortality in this series [7].
Diagnosis of HIV infection was made using methods
described previously [8]. All patients referred to A.I.I.M.S.
as 'HIV-positive' underwent retesting. Apart from this, all
patients treated for tuberculosis (TB), those reporting risk
factors for HIV infection and patients with clinical presen-
tation suggestive of underlying immunosuppression, were
offered HIV testing. All except one patient were infected
with HIV-1, the latter with HIV-2. CD4+ lymphocyte
counts were done by flowcytometry, using a FACSCalibur
flowcytometer (Becton Dickinson, USA) in patients who
could afford for the same. Patients were evaluated using a
predesigned instrument regarding the demographic char-
acteristics, risk factors for HIV infection, presenting symp-
toms, physical findings and laboratory parameters.
Various laboratory abnormalities were defined using cut-
off values as follows: anaemia – haemoglobin <100 g/L;
leucopenia – total leucocyte count (TLC) <4 × 109/L; lym-
phocytopenia – absolute lymphocyte count (ALC) <1.2 ×
109/L; decreased CD4+ – <500 cells/µL; thrombocytope-
nia – platelet count <150 × 109/L; elevated erythrocyte
sedimentation rate (ESR) – >20 in the first hour;
hypoalbuminaemia – albumin <35 g/L; hyperglobulinae-
mia – globulin >40 g/L; hyperbilirubinaemia – serum
total bilirubin >20.5 µmol/L; elevated liver enzymes – >2
times the upper limits of normal [aspartate aminotrans-
ferase (AST) – >100 IU/L, alanine aminotransferase (ALT)
– >100 IU/L, alkaline phosphatase (ALP) – >560 IU/L];
hypoxaemia – PaO2 <12 kPa; increased arterial-alveolar
oxygen gradient (A-a DO2) – >3.3 kPa, while breathing
ambient air (FiO2 = 0.21).
While genuine efforts were made to establish the diagno-
sis of an OI, patients at times were too sick to undergo
invasive diagnostic procedures such as bronchoscopy or
tissue biopsy and hence the following criteria were used to
define an OI concerned. Pulmonary tuberculosis (PTB):
clinical features suggestive of TB with radiological features
compatible with TB on chest radiograph or computed
tomographic scan (CT) and/or demonstration of acid-fast
bacilli (AFB) in sputum smears or growth of Mycobacte-
rium tuberculosis in sputum culture; disseminated tubercu-
losis (DTB): clinical features suggestive of TB with
concurrent involvement of at least two non-contiguous
organs, in the presence of bacteriological and/or his-
topathological evidence of TB and improvement with
anti-tuberculosis therapy; miliary tuberculosis (MTB):
clinical presentation consistent with TB and bacteriologi-
cal and/or histopathological evidence of TB and demon-
stration of bilateral miliary infiltrates on chest radiograph
or high-resolution CT; tuberculosis meningitis (TBM):
clinical and cerebrospinal fluid (CSF) features consistent
with tuberculosis meningitis, with bacteriologic demon-
stration of M. tuberculosis in CSF or after exclusion of other
aetiologies such as cryptococcus and syphilis, with evi-
dence of tuberculosis elsewhere and/or improvement
with anti-tuberculosis therapy; cryptococcal meningitis:
in CSF, demonstration of Cryptococcus sp. yeast cells by
India ink or antigen by latex agglutination or growth in
culture; cerebral toxoplasmosis: demonstration of multi-
ple ring-enhancing cerebral parenchymal lesions on con-
trast-enhanced CT or magnetic resonance imaging (MRI),
in the presence of anti-toxoplasma antibody in serum and
clinical response to anti-toxoplasma therapy; progressive
multifocal leucoencephalopathy (PMLE): compatiblePage 2 of 9
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cerebral white matter changes by MRI; Pneumocystis jiroveci
pneumonia (PCP): bilateral, diffuse interstitial infiltrates
on chest radiograph or high-resolution CT, with hypoxae-
mia (PaO2 <12 kPa) and sputum smears/cultures negative
for aerobic bacteria and AFB and/or demonstration of
Pneumocystis jiroveci in induced sputum [9].
Patients received primary chemoprophylaxis for PCP and
toxoplasmosis and received treatment for specific OIs fol-
lowed by secondary prophylaxis, as per recommendations
[10]. For patients with PCP, whenever hypoxaemia was
severe (PaO2 <9.3 kPa), corticosteroids were given in addi-
tion to oral co-trimoxazole. None of these patients
received assisted ventilation. All patients were counselled
and offered antiretroviral therapy, whenever indicated.
Upon discharge from the hospital, patients were advised
to follow-up as outpatients, on a regular and as needed
basis.
Statistical analysis
Entry and analysis of all data were done using a statistical
software package (SPSS for Windows, Version 10.0, SPSS
Inc., Chicago, IL). Entered data were double-checked for
discrepancies. Data are presented as mean ± standard
deviation (SD) when distributed normally and as median
with interquartile range (IQR), if the distribution was
skewed. Frequency of various clinical and laboratory find-
ings and the frequencies of individual OIs are expressed as
proportions (%). The relation between ALC and CD4+
count was analysed by Pearson's product moment correla-
tion. Paired-samples t-test was applied to assess the
improvement in CD4+ cell counts following antiretroviral
therapy.
Results
Over a period of about three and a half years, 135 patients
with HIV/AIDS were admitted and all these patients were
included in the study. Mean age of the study group was 34
± 10 (range: 13–73) years. Females constituted less than
one fourth of the study group (17%). Details of other
demographic characteristics and transmission categories
are presented in Table-1. More than two-thirds of patients
(76%) were in the second and third decades of their lives.
Labourers were the commonest occupational group
(40%) and long-haul truck drivers constituted a consider-
able proportion of the study group. Professionals were the
least common occupational group. An identifiable risk
factor for HIV infection was present in 59% of patients,
extramarital heterosexual contact being the commonest
(41.5%). None of the patients reported homosexual prac-
tices. About 40% of patients denied any risk factor for the
acquisition of HIV infection. A large number of patients
(44.4%) were from states other than Delhi.
Three symptoms namely fever, weight loss and diarrhoea
were the common symptoms at presentation (70.4%,
65.2% and 23.7% respectively). Productive cough and
dyspnoea were present in about a fourth of patients
(Table-2). Two-thirds of patients (66.7%) were malnour-
Table 1: Demographic characteristics and transmission-risk categories in a series of 135 patients with HIV/AIDS
Parameter Number of patients, n (%)
Age, in years (mean ± SD) 34 ± 10
Males 112(83)
Outside Delhi (n = 108) 48(44.4)
Occupation (n = 106)*
Unskilled labourer 31(29.2)
Skilled labourer 11(10.4)
Driver 11(10.4)
Police and armed forces 9(8.5)
Businessmen 19(17.9)
Clerical 5(4.7)
Professional 2(1.9)
Others 18(17)
Risk categories
Heterosexual contact 56(41.5)
IDU 5(3.7)
Blood transfusion 19(14.1)
Unknown† 55(40.7)
* 29 patients were unemployed; † Patients denied any of the known risk factors; IDU – Injectable drug users.Page 3 of 9
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phadenopathy was present in a considerable proportion
of patients (16.3%). Poor performance on mini mental
status examination (MMSE score <23) was not uncom-
mon (20.7%). Altered sensorium and focal neurologic
deficit were encountered occasionally. Anaemia was
present in about half of the patients (50.5%) and among
those who where anaemic, 17 (21.8%) patients were on
zidovudine. A considerable number of patients were leu-
copenic and in 22% of patients ALC was less than 1200/
µL (Table-3). CD4+ cell counts were done in 109 patients.
The distribution of CD4+ cell counts is shown in Figure-1.
Most of the patients (n = 90; 82.6%) had CD4+ counts
less than 200 cells/µL. Fifty patients (46%) had CD4+
counts less than 50 cells/µL. The correlation of ALC with
CD4+ count was not significant (r = 0.14; P = 0.18). HIV
viral load estimation was done in only four patients
(range 33752–289176 RNA copies/mL). Twenty patients
(14.8%) had hypoxaemia. Of these, five patients had PCP
(Figure 2-A), ten had DTB, three had extensive PTB and
one patient had massive unilateral tuberculosis pleural
effusion.
The mean number of OI was 1.4 per patient. The com-
monest OI was TB (71.1%), followed by oral candidiasis
(39.3%). Most of the cases of TB were disseminated (64%;
Figure 2-B) and PTB was seen in only a small number of
patients (8.1%). Eleven patients had MTB (Table-4). Of
the 53 patients with oral candidiasis, five patients had
concomitant oesophageal involvement. Cryptosporidium
sp. and Giardia sp. infection causing diarrhoea was found
in three and two patients respectively. Of the 13 cases of
meningitis, eight were tuberculosis and the rest due to
Cryptococcus sp.; no case of acute, pyogenic meningitis
was seen. Cerebral toxoplasmosis (Figure 2-C) and one
case of PMLE were the other central nervous system infec-
tions seen.
Table 2: Presenting features and physical findings in a series of 135 patients with HIV/AIDS
Symptoms and signs Frequency* n (%)
Fever 95(70.4)
Weight loss 88(65.2)
Cough 57(42.2)
Expectoration 38(28.1)
Dyspnoea 34(25.2)
Diarrhoea 32(23.7)
Abdominal pain 31(23)
Vomiting 22(16.3)
Night sweats 19(14.1)
Chest pain 17(12.6)
Haemoptysis 4(3)
Altered sensorium 5(3.7)
Seizures 4(3)
Body mass index <19 kg/m2 (n = 78) 52(66.7)
Midarm circumference†, in cm (mean ± SD) (n = 76) 18.9 ± 4.2
Triceps skin-fold thickness†, in mm (mean ± SD) (n = 78) 6.9 ± 1.7
Lymphadenopathy – cervical 39(28.9)
– axillary 32(23.7)
– mediastinal 18(13.3)
– retroperitoneal 15(11.1)
– generalised 22(16.3)
Hepatomegaly 29(21.5)
Splenomegaly 24(17.8)
Pleural effusion 15(11.1)
Ascites 3(2.2)
Pericardial effusion 3(2.2)
Jaundice 9(6.7)
MMSE score <23 28(20.7)
Nuchal rigidity 12(8.9)
Focal neurologic deficit 8(5.9)
* The denominator is 135, except for anthropometric parameters, where the number of patients is given in parentheses; † Measured at midpoint 
between acromian and olecranon processes of non-dominant arm: mean of three consecutive readings was taken; MMSE – Mini mental status 
examination.Page 4 of 9
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presented as recent onset dilated cardiomyopathy with no
features to suggest a central nervous system pathology. On
further investigation, the patient was found to be
seropositive for anti-toxoplasma antibodies and contrast
enhanced CT revealed multiple ring enhancing cerebral
lesions. The cerebral lesions cleared and cardiac ejection
fraction improved with anti-toxoplasma treatment. The
cardiac dysfunction was probably due to toxoplasma
myocarditis. Ten patients presented with PCP (Figure 2-A)
and three patients had cytomegalovirus (CMV) retinitis
(Figure 2-D). One patient was diagnosed as disseminated
histoplasmosis. This patient presented as fever of
unknown origin. Bone marrow biopsy revealed caseating
granulomas and subsequently fungal culture grew Histo-
plasma capsulatum. Non-infectious AIDS-defining condi-
tions were not common. One case of B-cell non-
Hodgkin's lymphoma presenting as unilateral maxillary
swelling (Figure 2-E) and another case of Hodgkin's lym-
phoma that presented as generalised lymphadenopathy
with hepatosplenomegaly, were seen.
Only 50 patients (37%) received antiretroviral therapy, of
which three patients were taking protease inhibitor (PI)
based regimens. All other patients received non-nucleo-
side reverse transcriptase inhibitor (NNRTI) based (nevi-
rapine – 46 patients, efavirenz – one patient) triple-drug
regimens. Follow-up CD4+ counts were done in 16
patients after three to six months of antiretroviral therapy.
The mean CD4+ count increased to 224 ± 178 cells/µL
from a baseline mean of 131 ± 122 cells/µL, which was
statistically significant (P = 0.003). Myelosuppression
during antiretroviral therapy developed in four patients,
who were taking regimens containing zidovudine. One
patient who was on didanosine developed acute pancrea-
titis (Figure 2-F). Another patient presented with severe,
uncompensated, wide anion-gap metabolic acidosis with
no apparent cause. This was probably due to lactic acido-
sis caused by stavudine, which he had been taking.
Twenty one patients (15.6%) died in hospital, most of
them due to TB (16 patients) and PCP (4 patients). All
patients who died in hospital except for one, had CD4+
counts less than 200 cells/µL (Figure-1).
Table 3: Laboratory findings in a series of 135 patients with HIV/AIDS
Variable Unit Mean ± SD Range Abnormality*%
Haemoglobin g/L 98 ± 27 33 – 161 50.5
TLC × 109/L 6.2 ± 2.8 0.9 – 15.3 17.3
Platelet count × 109/L 267 ± 183 56 – 960 19.3
ESR mm/hr 56 ± 18 12 – 91 96.2
ALC × 109/L 1.7 ± 0.8 0.1 – 3.6 22
CD4+ cell count (n = 109) per µL 121 ± 205 0 – 1425 98.2
Serum albumin g/L 30 ± 8 16 – 51 70.7
Serum globulin g/L 45 ± 11 21 – 76 70.3
Serum bilirubin – total µmol/L 18.8 ± 32.5 3.4 – 220.6 6.7
AST IU/L 77 ± 113 2 – 790 17
ALT IU/L 76 ± 92 2 – 682 22.3
ALP IU/L 360 ± 419 44 – 2355 11.1
PaO2 (n = 31) kPa 10.6 ± 3.7 4.6 – 19.4 14.8†
A-a DO2 (n = 31) kPa 2.8 ± 2.4 0 – 7.5 7.4†
* Defined by cut-off values as mentioned in the text; † Denominator was taken as 135; TLC – Total leucocyte count; ALC – Absolute lymphocyte 
count; ESR – Erythrocyte sedimentation rate; AST – Alanine aminotransferase; ALT – Aspartate aminotransferase; ALP – Alkaline phosphatase; 
PaO2 – Partial pressure of oxygen; A-a DO2 – Arterial-alveolar oxygen gradient.
Distribution of CD4+ cell counts and in-hospital deaths in the espective groupsFigure 1
Distribution of CD4+ cell counts and in-hospital deaths in 
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BMC Infectious Diseases 2004, 4:52 http://www.biomedcentral.com/1471-2334/4/52A – Chest radiograph of a patient with Pneumocystis jiroveci pneumonia showing bilateral, diffuse interstitial infiltratesFigure 2
A – Chest radiograph of a patient with Pneumocystis jiroveci pneumonia showing bilateral, diffuse interstitial infiltrates B – Con-
trast enhanced computed tomographic (CT) scan of chest showing mediastinal lymphadenopathy in a patient with disseminated 
tuberculosis. Typical central necrosis evident as low attenuation areas (arrows) is seen C – Contrast enhanced CT scan of 
brain showing ring enhancing lesions in the basal ganglia bilaterally (arrows). Serology was positive for toxoplasma infection D 
– Ophthalmoscopic image of a patient with cytomegalovirus retinitis E – Non-Hodgkin's lymphoma in a HIV-infected lady pre-
senting as unilateral maxillary swelling F – Contrast enhanced CT scan of abdomen reveals an oedematous and enlarged pan-
creas (asterisk) suggestive of acute pancreatitis. The patient was on didanosine and improved following withdrawal of the same 
and supportive treatment.Page 6 of 9
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Opportunistic infections (OIs) are the major cause of
morbidity and mortality in patients with HIV infection. In
resource-limited settings, knowledge regarding the preva-
lence of various OIs might aid in making decisions regard-
ing empirical treatment and would help to prioritise
limited resources. To this end, we studied the frequency of
various opportunistic conditions in this series of 135 HIV-
infected patients. Nearly a half of these patients came
from places other than New Delhi, being referred by
medical practitioners or approached on their own. In
India, HIV-infected patients are usually treated in tertiary
level centres, due to lack of expertise and facilities in pri-
mary and district level hospitals. Moreover, for reasons of
privacy patients and their kin prefer treatment at places far
off from their home towns. This series comprises
predominantly of patients from the northern states of
India. Hence the findings of the present study may not
apply to south India and north-east Indian states. Moreo-
ver, being a hospital based study, patients with severe ill-
ness causing rapid death and patients with milder
symptoms who prefer treatment from local health facili-
ties may not have been proportionately represented in the
study group.
Most of the patients were in the age group 21–40 years
and males were predominantly affected. This is similar to
nation-level statistics in which, of the 57781 cases of HIV/
AIDS reported to the National AIDS Control Organisation
(NACO), 89% of the cases were in the age group 15–44
years and 74% were males [11]. This section of the popu-
lation is more affected because they are sexually more
active and the social structure is patriarchal. Unfortu-
nately, these patients also happen to be in the economi-
cally most productive years of their lives. The male
preponderance might have been due to the fact that in the
existing social milieu, females do not seek medical care
fearing ostracism and loss of family support. Interestingly,
a large number of patients (41%) did not give a history of
any of the known risk factors for the acquisition of HIV
infection and homosexual practice was singularly not
seen. It is likely that these patients were reluctant to reveal,
due to the prevailing social values, which discourage
polygamy and homosexuality. For the same reason,
despite a history of prior blood transfusion in a consider-
able proportion of patients, it may not be possible to
ascribe causation; not all these patients would have
acquired HIV infection through blood transfusion. Inject-
able drug users (IDU) constituted only a minority of the
study group as has been observed in other parts of India
except for the north-eastern states where IDU is widely
prevalent [12].
Table 4: Opportunistic infections and HIV-related conditions in a series of 135 patients with HIV/AIDS and in-hospital outcomes
Diagnosis Frequency n*(%) CD4+ count median (IQR) In-hospital deaths, n†(%)
Tuberculosis – any organ 96(71.1) 46 (12–121) 16(16.7)
PTB 11(8.1) 46 (5–218) 3(27.3)
Pleural 4(3) 52 (5–276) --
LNTB 1(0.7) 37‡ --
TBM 8(5.9) 58 (5–165) 1(12.5)
DTB 61(45.2) 47 (15–127) 11(18)
MTB 11(8.1) 27 (5–57) 1(9.1)
Candidiasis 53(39.3) 54 (12–77) 9(17)
PCP 10(7.4) 38 (8–69) 4(40)
Herpes Zoster 8(5.9) 91 (59–151) 1(12.5)
Cryptococcal meningitis 5(3.7) 135 (14–320) 2(40)
Toxoplasmosis 5(3.7) 72 (21–132) 1(20)
Cryptosporidiosis 3(2.2) 61 (5–116) --
CMV retinitis 3(2.2) 127 (37–150) 1(33.3)
Giardiasis 2(1.5) 59 (1–116) --
Visceral leishmaniasis 2(1.5) 41 (5–77) --
Lymphoma 2(1.5) 145 (29–261) 1(50)
Disseminated histoplasmosis 1(0.7) 51‡ --
CMV oesophagitis 1(0.7) 8‡ --
PMLE 1(0.7) 62‡ --
* Not mutually exclusive; † Total will exceed the mortality of the study group; ‡ Single value; – No deaths; IQR – interquartile range; PTB – 
pulmonary tuberculosis; Pleural – tuberculosis pleural effusion; LNTB – lymph node tuberculosis; TBM – tuberculosis meningitis; DTB – 
disseminated tuberculosis; MTB – miliary tuberculosis; PCP – Pneumocystis jiroveci pneumonia; CMV – Cytomegalovirus; PMLE – progressive 
multifocal leucoencephalopathy.Page 7 of 9
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rhoea were common presenting features. In this series of
patients, all of whom had some opportunistic condition
at presentation indicating advanced HIV disease, wasting
is anticipated. The association of severe weight loss at
presentation with TB in HIV-infected patients has been
reported before [13]. TB was very common in this series
and was the commonest OI. Previous studies also confirm
the high prevalence of TB in HIV-infected individuals in
India [4,9,14,15]. Most of these cases of TB were either
disseminated or extra-pulmonary. We have previously
reported the increased prevalence of HIV seropositivity
among cases of extrapulmonary TB as compared to PTB
and as such, HIV co-infection is now on the rising trend
among cases of TB, in this population [16]. This trend is
in consonance with findings from across the globe. The
cases of TB attributable to HIV are increasing and have
reached alarming proportions in certain countries. An
example of such a nation is the United States of America,
where almost 26% of cases of TB are now attributable to
HIV infection [17]. Although these figures are from coun-
tries where the incidence of TB has otherwise been low, it
is bound to be similar in countries where TB is endemic.
PCP was seen in only a small number of patients. This is
in sharp contrast with western populations where PCP is
the commonest AIDS-defining illness [18]. Earlier studies
from India also have reported a low prevalence (6–7%) of
PCP [9,14]. The low prevalence of PCP in developing
countries is well known and the incidence is probably
increasing [19].
The frequencies of various OIs as observed in the present
study are similar to those reported earlier from other parts
of India [4,9,14,15]. Some of the opportunistic condi-
tions were conspicuous by their absence. Disseminated
infection caused by the fungus Penicillium marneffei has
been reported to be the third commonest OI in southeast
Asia [20] and is known to be highly prevalent in the
north-east Indian state, Manipur [21] which shares com-
mon geographic, ecologic and climatic conditions with
the south-east Asian regions of P. marneffei endemicity.
No case of P. marneffei infection was found in the present
study. Kaposi's sarcoma, atypical mycobacterial infection
and disseminated CMV disease were not seen, as has been
observed by a previous study from south India [14]. It
appears that, TB being an endemic infection in this popu-
lation, takes its toll before other less virulent pathogens
could come into play. Development of TB per se might
have afforded some protection against atypical mycobac-
terial disease [22]. It is also possible that TB masked the
recognition of other OIs, which might have been present
since it is well known that a large number of potentially
fatal OIs are not diagnosed antemortem [23,24]. In India,
Kaposi's sarcoma occurring in the setting of HIV infection
and other immunocompromised conditions is a rarity,
though not undescribed [25-27]. As such the prevalence
of human herpes virus-8 (HHV-8) infection among the
healthy population in India is low when compared with
African nations and this is also likely to be responsible for
the rarity of Kaposi's sarcoma [28]. Apart from the well-
recognised OIs, infection unique to the local population
namely, visceral leishmaniasis occurs in association with
HIV and this has to be borne in mind.
Overall in-hospital mortality in this series is considerable
and is probably reflective of the advanced nature of dis-
ease at presentation. This is evidenced by the fact that
more than 80% of patients had CD4+ counts less than
200 cells/µL and all but one deaths occurred in this group.
However, as we had reported earlier, CD4+ cell counts do
not determine the immediate outcome of patients with an
OI, whereas the latter does [7]. The proximate causes of
death in these patients are OIs, which are amenable to
effective treatment. Many of these patients were from poor
socioeconomic strata and were not able to afford for
antiretroviral therapy. Cost constraints directly or indi-
rectly, probably also resulted in poor compliance with
scheduled follow-up visits. With the implementation of
World Health Organisation sponsored '3 by 5' initiative,
it is hoped that antiretroviral therapy will be within the
reach for a large number these patients and also compli-
ance is likely to become better.
Conclusions
A wide spectrum of OIs is seen in hospitalised patients
with HIV/AIDS from north India. Tuberculosis is the most
common OI in this group of patients. Though uncom-
mon, non-infectious opportunistic conditions also occur.
Many patients suffer from more than one OI. Hospital
mortality is significant, with TB and PCP being responsi-
ble for most of these deaths. Whenever a definite diagno-
sis is not established quickly, empirical treatment should
be considered. Such an approach is likely to improve
immediate outcome in hospitalised patients with HIV/
AIDS.
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